Excellent report
28% improved pcp revenue growth
2.5% improved GM % on last half and 7% on pcp
If these trends continue we could be looking at NPAT in the vicinity of 1.2M for the FY, which in the context of operating leverage and 30% growth should command a multiple of 20x at least in this market or a market cap of 24M (0.68/share, a 15x multiple would be 0.51/share)
Excellent results.
Excellent report28% improved pcp revenue growth2.5% improved GM...
Add SRH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.791M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| SRH (ASX) Chart |
Day chart unavailable